Related Experiment Video
Updated: Jul 7, 2026
10:14
Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
[Age-related macular degeneration]
1Département universitaire d'ophtalmologie, centre hospitalier intercommunal de Créteil-universitaire Paris-12, 94010 Créteil, France. vincent.parier@chicreteil.fr
La Revue De Medecine Interne
|February 12, 2008
Summary
Age-related macular degeneration (AMD) is a leading cause of irreversible blindness. New anti-angiogenic therapies offer hope for preserving sight in patients with wet AMD.
Area of Science:
- Ophthalmology
- Genetics
- Medical Research
Background:
- Age-related macular degeneration (AMD) is a significant cause of irreversible blindness in individuals over 50.
- Its pathogenesis involves complex genetic and environmental interactions, remaining incompletely understood.
- Traditional classification includes early/late and dry/wet forms, with advanced imaging aiding diagnosis.
Purpose of the Study:
- To review current understanding and management of age-related macular degeneration (AMD).
- To highlight diagnostic advancements and therapeutic options for AMD.
- To discuss the potential of emerging anti-angiogenic treatments.
Main Methods:
- Review of existing literature on AMD pathogenesis and treatment.
- Analysis of diagnostic tools like fluorescein angiography, indocyanine green angiography, and optical coherence tomography.
- Evaluation of therapeutic interventions including laser photocoagulation, photodynamic therapy, and anti-angiogenic agents.
Main Results:
- Dietary supplements may benefit patients with age-related maculopathy.
- Laser photocoagulation is effective for specific lesion types.
- Photodynamic therapy with verteporfin benefits subfoveal classic lesions.
- Anti-angiogenic therapies targeting vascular endothelial growth factor show promise for sight preservation.
Conclusions:
- Emerging anti-angiogenic therapeutics targeting neovascularization will expand treatment options for exudative AMD.
- Continued research into AMD pathogenesis and novel treatments is crucial for improving patient outcomes.
More Related Videos
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:22Photoreceptors and Visual Pathways
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...